Advances in the Management of Diabetes 2022
Tracking # 20-912414
Price not reported
There are no ratings for this course
Learn moreCourse overview
At the conclusion of this program, the participant will be able to: 1. Review recent updates to the standards of care recommended by the American Diabetes Association. 2. . Describe recent cardiovascular and renal outcome trials for new diabetes medications and their implications for patient care. 3. Develop a plan to safely initiate and intensify insulin therapy using guideline recommendations and patient characteristics. 4. Evaluate the use of continuous glucose monitoring (CGM) devices in the management of diabetes. 5. Optimize pharmacotherapy for a patient with diabetes using glucose data.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Licensed Psychiatric Technician Nurse
Registered Nurse
Registered Nurse Practitioner
District of Columbia Board of Nursing
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Registered Nurse Anesthetist
Florida Board of Pharmacy
Pharmacist
Registered Pharmacy Technician
Florida Physician Assistants
Physician Assistant
Georgia Board of Nursing
Licensed Practical Nurse
Registered Professional Nurse
New Mexico Board of Nursing
Certified Hemodialysis Technician
Certified Hemodialysis Technician II
Certified Medication Aide II
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
New Mexico Medical Board
Medical Doctor
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
State Medical Board of Ohio
Doctor of Osteopathic Medicine
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Disclosure statements
Dr. Trujillo is a consultant to Sanofi and served on advisory board for BD Pharmaceuticals